AGP Picks
View all

Cyprus Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cyprus Healthcare Press.

Press releases published on November 4, 2026

FocalTherics™ to Participate in Upcoming Investor Conferences
Eton Pharmaceuticals to Present at 2026 Jefferies Global Healthcare Conference in London
Edesa Biotech to Present at Guggenheim Healthcare Innovation Conference
STERIS Announces Financial Results for Fiscal 2027 Second Quarter
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
OPKO Health Reports Third Quarter 2026 Business Highlights and Financial Results
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Solid Biosciences Reports Third Quarter 2026 Financial Results and Provides Business Updates
Annovis Announces Launch of Proposed Public Offering
Damora Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
Agomab to Participate in Upcoming Investor Conferences
Cytek Biosciences Reports Third Quarter 2026 Financial Results
Immuneering to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
ADMA Biologics Reports Third Quarter 2026 Financial Results and Provides Business Update
Relay Therapeutics Reports Third Quarter 2026 Financial Results and Corporate Updates
Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026
Larimar Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
Vaxcyte Reports Third Quarter 2026 Financial Results and Provides Business Update
Clover Health Reports Third Quarter 2026 Results
PROCEPT BioRobotics Reports Third Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Cyprus Healthcare Press

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.